Aberrant post‐translational modifications in endosomal trafficking are potential therapeutic targets to avert therapy resistance in solid cancers-Reference-Cited by-同舟云学术

Aberrant post‐translational modifications in endosomal trafficking are potential therapeutic targets to avert therapy resistance in solid cancers

Published:2021-12-16 Issue:2 Volume:44 Page:2100192
ISSN:0265-9247
Container-title:BioEssays
language:en
Short-container-title:BioEssays

Author:

Onglao Winona¹²,Khew‐Goodall Yeesim¹²³^ORCID,Belle Leila¹,Lonic Ana¹

Affiliation:

1. Centre for Cancer Biology An Alliance of SA Pathology and the University of South Australia Adelaide South Australia Australia

2. Department of Molecular and Biomedical Science School of Biological Sciences University of Adelaide Adelaide South Australia Australia

3. The Discipline of Medicine Faculty of Health and Medical Sciences University of Adelaide Adelaide South Australia Australia

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bies.202100192

Reference55 articles.

1. Receptor Tyrosine Kinase-Targeted Cancer Therapy

2. Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy

3. TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

4. A perspective on anti‐EGFR therapies targeting triple‐negative breast cancer;Nakai K.;American Journal of Cancer Research,2016

5. Receptor tyrosine kinases (RTKs) in breast cancer: Signaling, therapeutic implications and challenges;Butti R.;Molecular Cancer [Electronic Resource],2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma;Neuro-Oncology;2024-03-20